Skip to main content
Premium Trial:

Request an Annual Quote

NIGMS Grant Funds Insilicos' Software Development

NEW YORK (GenomeWeb News) — Insilicos has been awarded a grant from the National Institutes of Health in order to study a statistical methodology that can be applied to biomedical research, the company said yesterday.

The company will use the roughly $400,000 in funds from the National Institute of General Medical Sciences to continue developing a technique called Least Angle Regression, or LARS, which is used to produce stable predictions from data with a large number of dimensions.

"LARS is showing exciting results in life science and other areas," Insilicos CEO Erik Nilsson said in a statement.

Nilsson said the company takes a system biology approach toward disease diagnosis in areas "where we see disease as a breakdown of molecular communication in the body. When you measure this breakdown, you have lots of different signals to choose from, different molecules you can measure. We use LARS as a way of selecting the most promising signals and using these signals to predict disease."

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.